Stock Markets March 30, 2026

Broad Market Moves: Micron Slumps as Sysco, United Therapeutics Drive Large Swings

Mega-cap technology names retreat while targeted biotech and foodservice stories produce outsized moves across large-, mid- and small-cap stocks

By Hana Yamamoto MU LRCX INTC AMAT GEV
Broad Market Moves: Micron Slumps as Sysco, United Therapeutics Drive Large Swings
MU LRCX INTC AMAT GEV

Monday's trading session produced a wave of pronounced share-price changes across market-cap tiers. Leading semiconductor names and related equipment suppliers posted notable declines, while select healthcare and foodservice-related names recorded sharp moves tied to trial results and M&A reports. Below is a sector-driven roundup of the largest percentage movers, organized by market-cap group.

Key Points

  • Semiconductor and equipment stocks dominated declines among mega-cap names, pressuring technology-related indices.
  • Clinical trial outcomes and reported M&A activity led to outsized gains for select healthcare and foodservice/consumer distribution names.
  • Mid- and small-cap segments experienced elevated idiosyncratic volatility with multiple double-digit percentage moves.

Stocks across multiple market-cap brackets moved sharply Monday as company-specific developments and broader sector sentiment pushed prices in both directions. Semiconductor makers and their equipment suppliers featured prominently among declines, while biotechnology and certain consumer and distribution names posted gains tied to clinical results and transaction reports.


Market snapshot - biggest movers by market-cap tier

The lists below show the largest percentage changes observed during Monday's session, arranged by market-cap classification. Percent changes and attached notes are reproduced from reported intraday moves.

Mega-Cap Movers

  • Micron Technology (MU): -8.07%
  • Lam Research Corp (LRCX): -5.0%
  • Intel Corp (INTC): -4.1%
  • Applied Materials Inc (AMAT): -4.15%
  • GE Vernova LLC (GEV): -4.41%
  • Caterpillar (CAT): -3.69%
  • General Electric (GE): -3.48%
  • Cisco Systems Inc (CSCO): -3.11%
  • Advanced Micro Devices (AMD): -2.65%
  • Pepsico (PEP): +2.91%

Large-Cap Stock Movers

  • Sysco Corp (SYY); Sysco nearing deal for Restaurant Depot for $29B including debt - WSJ: -14.73%
  • Bloom Energy Corp (BE): -11.49%
  • PayPay Corp (PAYP): -11.15%
  • Astera Labs (ALAB): -11.1%
  • Planet Labs PBC (PL): -10.47%
  • Coherent (COHR): -9.96%
  • Yandex (NBIS): -9.58%
  • Fabrinet (FN): -9.97%
  • Iris Energy (IREN): -9.94%
  • United Therapeutics Corp (UTHR); United Therapeutics’ Tyvaso meets primary endpoint in IPF trial: +12.91%

Mid-Cap Stock Movers

  • Fundrise Innovation Fund (VCX): -40.01%
  • Signal Genetics (VRDN); Viridian reports positive phase 3 trial results for TED drug: -33.08%
  • Alumis (ALMS): -19.19%
  • nLIGHT Inc (LASR): -15.56%
  • Applied Opt (AAOI): -14.76%
  • Applied Blockchain (APLD): -14.67%
  • AXT Inc (AXTI): -11.84%
  • Good Works Acquisition (CIFR): -11.53%
  • Churchill Capital (INFQ): -12.08%
  • Peabody Energy Corp-Exch (BTU): -10.8%

Small-Cap Stock Movers

  • Roma Green Finance (ROMA); Roma Green Finance authorizes $100M share buyback program: -31.74%
  • Bleichroeder Acquisition I (MRLN): -19.11%
  • MUU (MUU): -16.32%
  • Neumora Therapeutics (NMRA); Neumora beats Q4 earnings expectations amid pipeline progress, stock falls 2%: -16.09%
  • CF Acquisition V (SATL); Cantor sees NASA initiatives boosting Rocket Lab, Intuitive Machines: -15.51%
  • LITX (LITX): -11.97%
  • Polaryx Therapeutics Inc (PLYX): -13.99%
  • SNXX (SNXX): -13.71%
  • Compass Diversified Holdings (CODI); Compass Diversified to sell Sterno food service unit for $292.5M: +15.72%
  • Fast Acquisition Corp II (FBYD): +19.63%

Analysis and context

Monday's tape was characterized by stark sector divergences. Semiconductor names and their equipment suppliers led the list of declines in the mega-cap group, while biotech trial news and transaction-related headlines drove some of the largest positive moves among large- and small-cap names. Notably, Sysco traded lower amid reporting that it is nearing a deal for Restaurant Depot for $29 billion including debt, and United Therapeutics climbed after a trial update tied to Tyvaso.

Key points

  • Semiconductor and equipment stocks were among the heaviest decliners, impacting mega-cap movers such as Micron, Lam Research and Applied Materials - sector: technology/semiconductors.
  • Clinical trial outcomes and corporate transaction reports produced outsized gains for select names, including United Therapeutics and Compass Diversified - sectors: healthcare, consumer/distribution.
  • Mid- and small-cap segments showed pronounced volatility with several double-digit percentage moves in both directions, underscoring elevated idiosyncratic risk - sectors: varied, including energy, biotech and financial vehicles.

Risks and uncertainties

  • Company-specific news such as M&A reports can trigger steep declines or gains, as seen with Sysco's reported Restaurant Depot discussions - impacts corporate and distribution sectors.
  • Clinical trial announcements may produce large stock moves that do not necessarily reflect broader sector trends, evident in the United Therapeutics and Signal Genetics lines - impacts healthcare and biotech.
  • Mid- and small-cap names displayed high volatility with several large percentage moves, which introduces execution and liquidity risk for investors in those segments - impacts small/mid-cap markets.

Investors tracking market movers should note that the session included a mix of announcement-driven swings and sector pressure, and individual stock outcomes varied sharply across market-cap tiers.

Risks

  • M&A-related headlines can cause material share-price declines or gains for companies tied to transaction reports, notably impacting the distribution and consumer sectors.
  • Clinical trial results create significant one-off moves in biotech and healthcare stocks that may not reflect broader sector health.
  • High percentage swings in mid- and small-cap stocks signal elevated liquidity and idiosyncratic risk for investors in those segments.

More from Stock Markets

U.S. Equipment Financing Climbs 14.2% Year‑Over‑Year in February, ELFA Survey Shows Mar 30, 2026 Strategy Inc. Halts Week-to-Week Bitcoin Purchases After 13 Consecutive Weeks Mar 30, 2026 Boston Scientific Shares Drop After CHAMPION-AF Data Shows Mixed Results for Watchman Implant Mar 30, 2026 Goldman Sachs Flags Stagflation Risk as Oil Spike Adds Stress to Multi-Asset Portfolios Mar 30, 2026 JetBlue Raises First Checked Bag Fee to $49 as Fuel Costs Climb Mar 30, 2026